A tissue engineering approach to regenerate the cranial suture skeletal stem cell niche with a multicompartment biomaterial scaffold

Abstract

Craniosynostosis is a debilitating congenital anomaly characterized by the premature fusion of cranial sutures in the skull, resulting from the abnormal fate specification of critical skeletal stem cells. This leads to disrupted craniofacial development and dysmorphology. As an alternative to invasive cranial vault remodeling surgery, we propose a tissue engineering approach to effectively restore the damaged or absent suture stem cell niche using a biomaterial capable of regioselective stem cell maintenance, marking a significant paradigm shift. By harnessing the role of biomaterial scaffold pore design to direct cell fate, we developed a “bone-suture-bone” design within a triphasic scaffold. We demonstrate that this unique scaffold design maintains stemness in a central region while promoting osteogenic differentiation in the surrounding areas, replicating the interfaces and function of the native suture. The scaffold’s ability to reconstitute an engineered skeletal stem cell niche and facilitate the functional recovery of the craniosynostosis phenotype is validated in a caBmpr1a; Wnt1-Cre murine model of midline craniosynostosis, the most common nonsyndromic clinical presentation in humans. This work shows significant promise for improving patient outcomes through a rational tissue engineering strategy for reconstituting a native stem cell niche.

References

[1] Betances, E. M., Mendez, M. D. & Joe, M. D. Craniosynostosis (StatPearls, 2023).

[2] Junaid M, et al.. Association between craniofacial anomalies, intellectual disability and autism spectrum disorder: Western Australian population-based study. Pediatr. Res, 2022, 92: 1795-1804.

[3] Shruthi NM, Gulati S. Craniosynostosis: a pediatric neurologist’s perspective. J. Pediatr. Neurosci., 2022, 17: S54-S60.

[4] Nguyen C, Hernandez-Boussard T, Khosla RK, Curtin CM. A national study on craniosynostosis surgical repair. Cleft Palate Craniofac. J., 2013, 50: 555-560.

[5] Borst AJ, et al.. Blood loss and transfusion in pediatric craniofacial surgery in the antifibrinolytic era. Blood, 2020, 136: 15-16.

[6] Bruce WJ, et al.. Age at time of craniosynostosis repair predicts increased complication rate. Cleft Palate Craniofac. J., 2018, 55: 649-654.

[7] McCarthy JG, et al.. Parameters of care for craniosynostosis. Cleft Palate Craniofac. J., 2012, 49: 1S-24S.

[8] Yin T, Li L. The stem cell niches in bone. J. Clin. Invest., 2006, 116: 1195-1201.

[9] Zhao H, et al.. The suture provides a niche for mesenchymal stem cells of craniofacial bones. Nat. Cell Biol., 2015, 17: 386-396.

[10] Maruyama, T., Jeong, J., Sheu, T.-J. & Hsu, W. Stem cells of the suture mesenchyme in craniofacial bone development, repair and regeneration. Nat. Commun.7, 10526 (2016).

[11] Maruyama, T. et al. BMPR1A maintains skeletal stem cell properties in craniofacial development and craniosynostosis. Sci. Transl. Med.13, eabb4416 (2021).

[12] Wilk K, et al.. Postnatal calvarial skeletal stem cells expressing PRX1 reside exclusively in the calvarial sutures and are required for bone regeneration. Stem Cell Rep., 2017, 8: 933-946.

[13] Mizuhashi K, et al.. Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature, 2018, 563: 254-258.

[14] Worthley DL, et al.. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell, 2015, 160: 269-284.

[15] Shi, Y. et al. Gli1 identifies osteogenic progenitors for bone formation and fracture repair. Nat. Commun.8, 2043 (2017).

[16] Jeffery EC, Mann TLA, Pool JA, Zhao Z, Morrison SJ. Bone marrow and periosteal skeletal stem/progenitor cells make distinct contributions to bone maintenance and repair. Cell Stem Cell, 2022, 29: 1547-1561.e1546.

[17] Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell, 2014, 15: 154-168.

[18] Pineault, K. M., Song, J. Y., Kozloff, K. M., Lucas, D. & Wellik, D. M. Hox11 expressing regional skeletal stem cells are progenitors for osteoblasts, chondrocytes and adipocytes throughout life. Nat. Commun.10, 3168 (2019).

[19] Sun J, et al.. A vertebral skeletal stem cell lineage driving metastasis. Nature, 2023, 621: 602-609.

[20] Li, B. et al. Cranial suture mesenchymal stem cells: insights and advances. Biomolecules11, 1129 (2021).

[21] Behr B, Longaker MT, Quarto N. Craniosynostosis of coronal suture in twist1 mice occurs through endochondral ossification recapitulating the physiological closure of posterior frontal suture. Front. Physiol., 2011, 2: 37.

[22] Ueharu H, et al.. Augmentation of BMP signaling in cranial neural crest cells leads to premature cranial sutures fusion through endochondral ossification in mice. JBMR, 2023, 7: e10716

[23] Hayano S, Komatsu Y, Pan H, Mishina Y. Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis. Development, 2015, 142: 1357-1367

[24] Komatsu Y, et al.. Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice. J. Bone Miner. Res., 2013, 28: 1422-1433.

[25] Kramer K, et al.. Rapamycin rescues BMP-mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model. Genesis, 2018, 56. ArticleID: e23220

[26] Jones DL, Wagers AJ. No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol., 2008, 9: 11-21.

[27] Hong L, Mao JJ. Tissue-engineered rabbit cranial suture from autologous fibroblasts and BMP2. J. Dent. Res., 2004, 83: 751-756.

[28] Yu M, et al.. Cranial suture regeneration mitigates skull and neurocognitive defects in craniosynostosis. Cell, 2021, 184: 243-256.e218.

[29] Omi, M. et al. Increased BMP-Smad signaling does not affect net bone mass in long bones. Front. Physiol.14, 1145763 (2023).

[30] Swanson, W.B., Mishina, Y. The biology of the sutures of the skull. In: Turgut, M., Tubbs, R.S., Turgut, A.T., Dumont, A.S. (eds) The Sutures of the Skull pp. 171–199 (Springer, 2021).

[31] Omi, M. et al. BMP-Smad signaling regulates postnatal crown dentinogenesis in mouse molar. JBMR Plus4, e10249 (2019).

[32] Fukuda T, et al.. Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2. Genesis, 2006, 44: 159-167.

[33] Woodbury, S. M., Swanson, W. B. & Mishina, Y. Mechanobiology-informed biomaterial and tissue engineering strategies for influencing skeletal stem and progenitor cell fate. Front. Physiol.14, 1220555 (2023).

[34] Swanson, W. B. et al. Scaffold pore curvature influences ΜSC fate through differential cellular organization and YAP/TAZ activity. Int. J. Mol. Sci.23, 4499 (2022).

[35] Swanson, W. B. et al. Macropore design of tissue engineering scaffolds regulates mesenchymal stem cell differentiation fate. Biomaterials, 272, 120769 (2021).

[36] Swanson, W. B. & Ma, P. X. In Biomaterials Science 601–622 (2020).

[37] Gupte MJ, et al.. Pore size directs bone marrow stromal cell fate and tissue regeneration in nanofibrous macroporous scaffolds by mediating vascularization. Acta Biomater., 2018, 82: 1-11.

[38] Zhang, P. et al. The physical microenvironment of hematopoietic stem cells and its emerging roles in engineering applications. Stem Cell Res. Ther.10, 327 (2019).

[39] Peerani R, Zandstra PW. Enabling stem cell therapies through synthetic stem cell–niche engineering. J. Clin. Invest., 2010, 120: 60-70.

[40] Velikic, G. et al. Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases. Int. J. Mol. Sci.25, 993 (2024).

[41] Humberto Valencia C. Hydrolytic degradation and in vivo resorption of poly-l-lactic acid-chitosan biomedical devices in the parietal bones of Wistar rats. J. Int Med Res, 2019, 47: 1705-1716.

[42] da Silva D, et al.. Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. Chem. Eng. J., 2018, 340: 9-14.

[43] Wei GB, Ma PX. Macroporous and nanofibrous polymer scaffolds and polymer/bone-like apatite composite scaffolds generated by sugar spheres. J. Biomed. Mater. Res. A, 2006, 78A: 306-315.

[44] Zhang N, et al.. Spontaneous osteogenic differentiation of mesenchymal stem cells on electrospun nanofibrous scaffolds. RSC Adv., 2016, 6: 22144-22152.

[45] Jones SJ, Boyde A. The migration of osteoblasts. Cell Tissue Res, 1977, 184: 179-193.

[46] Sehring, I. et al. Zebrafish fin regeneration involves generic and regeneration-specific osteoblast injury responses. Elife11, e77614 (2022).

[47] Song JY, Pineault KM, Dones JM, Raines RT, Wellik DM. Hox genes maintain critical roles in the adult skeleton. Proc. Natl. Acad. Sci. USA, 2020, 117: 7296-7304.

[48] Nelson LT, Rakshit S, Sun H, Wellik DM. Generation and expression of a Hoxa11eGFP targeted allele in mice. Dev. Dyn., 2008, 237: 3410-3416.

[49] Costes SV, et al.. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J., 2004, 86: 3993-4003.

[50] Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc, 1993, 169: 375-382.

[51] Pan H, Fleming N, Hong CC, Mishina Y, Perrien DS. Methods for the reliable induction of heterotopic ossification in the conditional Alk2(Q207D) mouse. J. Musculoskelet. Neuronal Interact., 2020, 20: 149-159

[52] Katsianou MA, Adamopoulos C, Vastardis H, Basdra EK. Signaling mechanisms implicated in cranial sutures pathophysiology: craniosynostosis. BBA Clin., 2016, 6: 165-176.

[53] Simpson A, Wong AL, Bezuhly M. Surgical correction of nonsyndromic sagittal craniosynostosis. Ann. Plast. Surg., 2017, 78: 103-110.

[54] Smith, L. A. & Ma, P. X. In Stem Cell Bioengineering and Tissue Engineering Microenvironment 205–217 (2011).

[55] Chan BP, Leong KW. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur. Spine J., 2008, 17: 467-479.

[56] Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials, 2005, 26: 5474-5491.

[57] Moioli EK, Clark PA, Sumner DR, Mao JJ. Autologous stem cell regeneration in craniosynostosis. Bone, 2008, 42: 332-340.

[58] Siismets, E. M. & Hatch, N. E. Cranial neural crest cells and their role in the pathogenesis of craniofacial anomalies and coronal craniosynostosis. J. Dev. Biol.8, 18 (2020).

[59] Mason DE, et al.. YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility. J. Cell Biol., 2019, 218: 1369-1389.

[60] Sousa-Ortega, A. et al. A Yap-dependent mechanoregulatory program sustains cell migration for embryo axis assembly. Nat. Commun.14, 2804 (2023).

[61] Nair PR, Wirtz D. Enabling migration by moderation: YAP/TAZ are essential for persistent migration. J. Cell Biol., 2019, 218: 1092-1093.

[62] Szydlak R. Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells. World J. Stem Cells, 2021, 13: 619-631.

[63] Lin W, et al.. Mesenchymal stem cells homing to improve bone healing. J. Orthop. Transl., 2017, 9: 19-27

[64] Su, P. et al. Mesenchymal stem cell migration during bone formation and bone diseases therapy. Int. J. Mol. Sci.19, 2343 (2018).

[65] He, Q. et al. TGF-β1-induced bone marrow mesenchymal stem cells (BMSCs) migration via histone demethylase KDM6B mediated inhibition of methylation marker H3K27me3. Cell Death Discov.8, 339 (2022).

[66] Leti Acciaro A, Lando M, Starnoni M, Giuca G, Adani R. Piezoelectric bone surgery. overview in applications and proof of feasibility in hand and plastic surgery. Indian J. Orthop., 2022, 56: 66-72.

[67] Hennet P. Piezoelectric bone surgery: a review of the literature and potential applications in veterinary oromaxillofacial surgery. Front Vet. Sci., 2015, 2: 8.

[68] Otake, Y., Nakamura, M., Henmi, A., Takahashi, T. & Sasano, Y. Experimental comparison of the performance of cutting bone and soft tissue between piezosurgery and conventional rotary instruments. Sci. Rep.8, 17154 (2018).

[69] Epah, J. et al. Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. BMC Med.21, 360 (2023).

[70] Hoch AI, Leach JK. Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl. Med., 2014, 3: 643-652.

[71] Yang, Y.-H. K., Ogando, C. R., Wang See, C., Chang, T.-Y. & Barabino, G. A. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem Cell Res. Ther.9, 131 (2018).

[72] Maridas, D. E., Rendina-Ruedy, E., Le, P. T. & Rosen, C. J. Isolation, culture, and differentiation of bone marrow stromal cells and osteoclast progenitors from mice. J. Vis. Exp.https://doi.org/10.3791/56750 (2018).

[73] Swanson WB, et al.. Macropore design of tissue engineering scaffolds regulates mesenchymal stem cell differentiation fate. Biomaterials, 2021, 272. ArticleID: 120769

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)(T32-DE007057)

RIGHTS & PERMISSIONS

The Author(s)